Permanent vascular accesses malfunction causes frequent and costly morbidity in hemodialysis patients.
OBJECTIVE
To evaluate which indicator (venous & arterial pressures, percent urea recirculation (BUN) , Doppler ultrasound, and access blood flow by ultrasound dilution technique) best predicts short-term access thrombosis and to better define the sensitivity and specificity of these measurements.
STUDY
• Three-center study of 220 vascular accesses in 170 hemodialysis patients (78% grafts, 22% AV fistulas); • Two 6-month study periods followed by three-month observation period;
• Various indicators (venous/arterial pressures, percent urea recirculation, Doppler ultrasound, and access blood flow) were simultaneously evaluated at blood flows of (200, 300 and 400 mL/min); • Short-term predictive power of access thrombosis was determined within subsequent 12 weeks of each study period. • Statistical analysis was limited to the polytetrafluoroethylene (PTFE) grafts, due to few number of thrombosis in AV fistulas.
RESULTS
• 34 thrombotic events in 172 PTFE grafts; one thrombotic event in 48 arteriovenous fistulas (AVF);
Hemodialysis CONCLUSIONS
• Access blood flow measured by either Ultrasound Dilution or Doppler Ultrasound is a reliable indicator of subsequent short-term thrombosis risk.
• Venous/arterial pressures, percent urea recirculation were not useful for evaluating access dysfunction.
• Access blood flow measurement will likely become the method of choice for screening of PTFE vascular access dysfunction in hemodialysis patients if simple-to-use and cost effective devices become available. • Blood flows determined Ultrasound Dilution and Doppler Ultrasound correlated well. The grade of stenosis determined by ultrasound was also a statistically significant predictor (P = 0.02); • Venous/arterial pressures were similar, but not statistically different between thrombosed and nonthrombosed accesses; • After adjustment for other variables, multivariate analysis showed that there was a significantly increased risk of thrombosis only with decreasing access blood flow determined by ultrasound dilution technique;
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• When 1134 mL/min was used as average graft blood flow as the reference, the relative risk of a PTFE thrombotic event within the subsequent 12 week observation period was 1.23 at a blood flow 950 mL/ min, 1.67 at a blood flow of 650 mL/min and to 2.39 at a blood flow of 300 mL/min.
